Portal de Periódicos da CAPES

Clinical Aspects of Ca‐blocking Agents.

1978; Wiley; Volume: 43; Issue: s2 Linguagem: Inglês

10.1111/j.1600-0773.1978.tb03567.x

0001-6683

Bengt W. Johansson,

Heart Failure Treatment and Management

Acta Pharmacologica et ToxicologicaVolume 43, Issue s2 p. 45-50 Clinical Aspects of Ca-blocking Agents. Bengt W. Johansson, Bengt W. Johansson Heart section, Dept. of Medicine, General Hospital, Malmö, SwedenSearch for more papers by this author Bengt W. Johansson, Bengt W. Johansson Heart section, Dept. of Medicine, General Hospital, Malmö, SwedenSearch for more papers by this author First published: November 1978 https://doi.org/10.1111/j.1600-0773.1978.tb03567.xCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1st International Nifedipine “Adalat” Symposium: New Therapy of Ischemic Heart Disease. Ed K. Hashimoto, E. Kimura & T. Kobauashi, University of Tokyo Press, Tokyo 1975. Google Scholar 2nd International Adalat Symposium: New Therapy of Ischemic Heart Disease. Ed W. Lochner, W. Braasch & G. Kroneberg, Springer Verlag, Berlin 1975. Google Scholar 3rd International Adalat Symposium: New Therapy of Ischemic Heart Disease. Ed A. Domingos Jatene & Paul R. Lichtlen, Excerpta Medica, Amsterdam 1976. Google Scholar Bengt W. Johansson & Gillis Johnsson: Läkemedel vid Angina Pectoris. Socialstyrelsens Kommitté för Läkemedelsinformation, 2: 1, maj 1971. Google Scholar Angina Pectoris — Isoptin. Ed J.-H. Atterhög, L. Sparre Hermann & J. Sieverts, AB Meda, Göteborg 1977. Google Scholar Symposium on Arrhythmias — Isoptin. Ed J.-H. Atterhög, A. Haakana & B. Nording, AB Meda, Göteborg 1974. Google Scholar Abelin, J.: From “ Discussion“ 3rd International Adalat Symoosium, Excerpta Medica. p. 244, Amsterdam 1976. Google Scholar Mc Arthur, J. D., R. G. Murray. A. Tweddel & T. D. V. Lawrie: Comparison of the Effect of Adalat and Propranolol on Exercise Tolerance in Patients with Angina Pectoris, 2nd International Adalat Symposium, Springer Verlag, p. 315, Berlin 1975. Google Scholar Atterhög, J.-H., L.-G. Ekelund & A.-L. Melin: Effect of nifedipine on exercise tolerance in patients with angina pectoris. Europ. J. Clin. Pharmacol. 1975, 8 125. 10.1007/BF00561561 CASPubMedWeb of Science®Google Scholar Bender, F.: Die Behandlung der Tachycarden Arrhythmien und der Arteriellen Hyiertonie mit Verapamil. Arzneimittel-Forsch, 1970, 20, 1310. PubMedWeb of Science®Google Scholar Bodeker, I, S. A. Salim & R. Nagel: Wirkungen von Nifedipine bei Urologischen Patienten. Dtsch. Med. Wschr. 1976, 101, 1866. 10.1055/s-0028-1104359 CASPubMedWeb of Science®Google Scholar Castro, I., S. W. Rocha & R. Rodrigues: Antianginal Efficacy and Tolerance of Adalat (BAY a 1040). Results of a Six-month Trial. 3rd International Adalat Symposium, Excerpta Medica, p. 255, Amsterdam 1976. Google Scholar Ebner, F. & H. B. Dünnschede: Haemodynamics, Therapeutic Mechanism of Action and Clinical Findings of Adalat Use based on Worldwide Clinical Trials. 3rd International Adalat Symposium, Excerpta Medica, p. 283, Amsterdam 1976. Google Scholar Ekelund, L.-G., & J.-H. Atterhög: Adalat and Beta Blockers; the Mechanism Studied with two Series of Work Tests in two Groups of Patients with Angina Pectoris. 2nd International Adalat Symposium, Springer Verlag, p. 169, Berlin 1975. Google Scholar Ekelund, L.-G. & L. Orö: Antianginal Efficiency of Adalat with and without a Beta-blocker. A Subacute Study with Exercise Tests. 3rd International Adalat Symposium, Excerpta Medica, p. 218, Amsterdam 1976. Google Scholar Ekelund, L.-G. & L. Orö: Antianginal efficiency of nifedipine (Adalat) with and without a beta-blocker, studied with exercise tests. A subacute study. Submitted to publication 1978. Google Scholar Esser, W., W. Herms & E. Wetzels: Die Wirkung verschiedener Koronardilatierender Pharmaka auf die Nierenfunktion. Ed B. Watschinger, Verlag der Wiener Medizinischen Akademie, p. 593, Wien 1969. Google Scholar Fagher, B., S. Persson & S. E. Svensson: Double-blind Comparison of Verapamil and Practolol in the Treatment of Angina Pectoris. Postgrad. Med. J. 1977, 53, 61. 10.1136/pgmj.53.616.61 CASPubMedWeb of Science®Google Scholar Fleckenstein, A., J. Janke, H. J. Döring & O. Leder: Myocardial Fiber Necrosis due to Intracel-Mar Ca Overload — a New Principle in Cardiac Pathophysiology. Recent Adv. Stud. Cardiac Struct. Metab. 1974, 4, 563–580. CASPubMedGoogle Scholar Gummerus, M.: Hemmung der drohenden Frühgeburt mit Nylidrin und Verapamil. Z. Geburtsh. Perinat. 1975, 179, 261. CASPubMedGoogle Scholar Hagman, M.: Effekt of BAY a 1040 jämfört med Aptin vid behandling av angina pectoris. Submitted to publication 1977. Google Scholar Henry, P. D.: Protection of Ischemic Myocardium by Nifedipine. 3rd International Adalat Symposium, Excerpta Medica, p. 55, Amsterdam 1976. Web of Science®Google Scholar Hoffman, P.: Behandlung Koronarer Durchblutunnsstörungen mit Isoutin in der Praxis. Med. Klin. 1964, 59, 1387. PubMedGoogle Scholar Hosoda, S. & E. Kimura: Efficacy of Nifedipine in the Variant Form of Angina Pectoris. 3ra International Adalat Symposium, Excerpta Medica, p. 195, Amsterdam 1976. Google Scholar Jasmin, G. & B. Solymoss: Prevention of Hereditary Cardiomyopathy in the Hamster by Verapamil and Other Agents. Proc. Soc. Exp. Biol. Med. 1975, 149, 193. 10.3181/00379727-149-38771 CASPubMedWeb of Science®Google Scholar Johansson, B. W.: Unpublished results. Google Scholar Johansson, B. W., K.-E. Anderson, H. Ledermann, H. von Schenk & I. J. Thorell: The Effects of Digoxin and Beta-methyl-digoxin on the Heart Rate of Decompensated Patients with Atrial Fibrillation. Europ. J. Clin. Investig. 1977, 7, 3. 10.1111/j.1365-2362.1977.tb01562.x CASWeb of Science®Google Scholar Kenmure, A. C. F. & J. H. Scruton: A Double-blind Controlled Trial of the Antianginal Efficacy of Nifedipine Compared with Propranolol. 3rd International Adalat Symposium, Excerpta Medica, p. 268, Amsterdam 1976. Google Scholar Krikler, D.: Verapamil in Cardiology, Europ. J. Cardiol. 1974, 2, 3. CASPubMedWeb of Science®Google Scholar Laaser, U., K. A. Meurer, H. Krüger & W. Kaufmann: Clinical Studies on the Combined Effect of Various Antihypertensive Agents and Adalat, 2nd International Adalat Symposium, Springer Verlag, p. 285, Berlin 1975. Google Scholar Levy, L.: Treatment for Hypertension. S. Afr. Med. J. 1973, 47: 676. CASPubMedWeb of Science®Google Scholar Livesley, B., P. F. Carley, R. C. Campell & S. Oram: Double-blind Evaluation of Verapamil, Propranolol and Isosorbide Dinitrate against a Placebo in the Treatment of Angina Pectoris. Brit, Med. J. 1973, 1, 375. 10.1136/bmj.1.5850.375 CASPubMedWeb of Science®Google Scholar Maroko, P. R. & E. Braunwald: Effects of Metabolic and Pharmacologic Interventions on Myocardial Infarct Size Following Coronary Occlusion. Circulation 1976, 53, suppl. 1, 162. Google Scholar Menna, J., M. Traina, E. Ferreirós & J. C. Cassera: Long-term Double-blind Cross-over Study on the Antianginal Efficacy of Adalat Compared with Placebo. 3rd International Adalat Symposium, Excerpta Medica, p. 282, Amsterdam 1976. Google Scholar Midtbö, K.: Isoptin, a Prophylactic Agent in Paroxysmal Supraventricular Tachyarrhythmias. A Double-blind Trial. Symposium on Arrhythmias — Isoptin, AB Meda, p. 100, Göteborg 1974. Google Scholar Mc Murtry, J. F., A. B. Davidson, J. T. Reeves & R. F. Grove: Inhibition of Hypoxic Pulmonary Vasoconstriction by Calcium Antagonists in isolated Rat Lungs. Circulation Res. 1976, 38, 99. 10.1161/01.RES.38.2.99 CASGoogle Scholar Rodrigues-Pereira, E. & A. P. Viana: The Actions of Verapamil on Experimental Arrhythmias. Arzneimittel-Forsch. 1968, 18, 175. CASPubMedWeb of Science®Google Scholar Schamroth, L., D. M. Krikler & C. Garrett: Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias. Brit. Med. J. 1972, 1, 660. 10.1136/bmj.1.5801.660 CASPubMedWeb of Science®Google Scholar Schamroth, L.: Immediate Effects of Intravenous Verapamil on Atrial Fibrillation. Cardiovasc. Res. 1971, 5, 419. 10.1093/cvr/5.4.419 CASPubMedWeb of Science®Google Scholar Schmid, J. R. & C. Hanna: A Comparison of the Antiarrhythmic Actions of two Synthetic Compounds, Iproveratril and MJ 1999, with Quinidine and Pronethalol. J. Pharmacol. Exp. Ther. 1967, 156, 331. CASPubMedWeb of Science®Google Scholar Singh, B. N. & E. M. Vaughan Williams: A Fourth Class of Antidysrhythmic Action? Effect of Verapamil on Ouabain Toxicity, on Atrial and Ventricular Intracellular Potentials, and on Other Features of Cardiac Function. Cardiovesc. Res. 1972, 6, 109. 10.1093/cvr/6.2.109 CASPubMedWeb of Science®Google Scholar Smith, H. J., B. N. Singh, H. D. Nisbet & R. M. Norris: Effects of Veraparnil on Infarct Size Following Experimental Coronary Occlusion. Cardiovasc. Res. 1975, 9, 569. 10.1093/cvr/9.4.569 CASPubMedWeb of Science®Google Scholar Storstein, O. & K. H. Landmark: Verapamil in the Treatment of Atrial Tachycardia with Block. Acta Med. Scand. 1975, 198, 483. 10.1111/j.0954-6820.1975.tb19579.x CASPubMedWeb of Science®Google Scholar Storstein, O. & K. Rasmussen: Digitalis and Atrial Tachycardia with Block. Brit. Heart J. 1974, 36, 171. 10.1136/hrt.36.2.171 CASPubMedWeb of Science®Google Scholar Tschirdewahn, B. & H. Klepzig: Klinische Untersuchung über die Wirkung von Isoptin und Isoptin S bei Patienten mit Koronarinsuffizienz. Dtsch. Med. Wschr.1963. 10.1055/s-0028-1112284 Web of Science®Google Scholar Citing Literature Volume43, Issues2November 1978Pages 45-50 ReferencesRelatedInformation